Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy

Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy

Lung cancer is a leading cause of cancer-related death, and patients with lung cancer are a priority group for influenza vaccination. However, few studies have assessed the immunogenicity of the influenza vaccine in these patients. Here, we performed a prospective study to evaluate the immunogenicit...

Full description

Bibliographic Details
Main Authors: Kei Nakashima, Masahiro Aoshima, Satoko Ohfuji, Kanzo Suzuki, Masahiro Katsurada, Naoko Katsurada, Masafumi Misawa, Yoshihito Otsuka, Kyoko Kondo, Yoshio Hirota
Format: Article
Language:English
Published: Taylor & Francis Group 2017-03-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
anticancer chemotherapy
chronic obstructive pulmonary disease
influenza vaccine
immunogenicity
lung cancer
Online Access:http://dx.doi.org/10.1080/21645515.2016.1246094

Similar Items

Similar Items